Next-generation oncolytic vaccinia vectors

Methods in Molecular Biology

Volumn 797, Issue , 2012, Pages 205-215

  Thorne, Steve H ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Oncolytic virus; Replication selective; Tumor targeting; Vaccinia; Virotherapy

Indexed keywords

ONCOLYTIC VIRUS;

ANIMAL; ARTICLE; CELL LINE; GENE VECTOR; GENETICS; HELA CELL; HUMAN; METHODOLOGY; MOUSE; NEOPLASM; ONCOLYTIC VIROTHERAPY; TRANSGENE; TUMOR CELL LINE; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; GENETIC VECTORS; HELA CELLS; HUMANS; MICE; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; TRANSGENES; VACCINIA VIRUS; VIRUS REPLICATION;

VACCINIA VIRUS;

EID: 80555144261     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-340-0_14     Document Type: Chapter

References (7)

1. Smith GL, Symons JA, Khanna A, Vanderplasschen A, Alcami A. 1997 Vaccinia virus immune evasion. Immunol Rev;159:137–54.
2. Buller RM, Palumbo GJ. 1991 Poxvirus pathogenesis. Microbiol Rev;55:80–122.
3. Thorne SH, Hwang TH, Kirn DH. 2005 Vaccinia virus and oncolytic virotherapy of cancer. Curr Opin Mol Ther;7:359–65.
4. Thorne SH, Kirn DH. 2004 Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus. Expert Opin Biol Ther;4:1307–21.
5. Chakrabarti S, Sisler JR, Moss B. 1997 Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques;23:1094–7.
6. Coupar BE, Oke PG, Andrew ME. 2000 Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein. J Gen Virol;81:431–9.
7. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. 2005 Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt;10:41210.